Company Quick10K Filing
LegacyTexas Financial
10-Q 2019-06-30 Filed 2019-07-24
10-Q 2019-03-31 Filed 2019-04-23
10-K 2018-12-31 Filed 2019-02-07
10-Q 2018-09-30 Filed 2018-10-24
10-Q 2018-06-30 Filed 2018-07-25
10-Q 2018-03-31 Filed 2018-04-25
10-K 2017-12-31 Filed 2018-02-08
10-Q 2017-09-30 Filed 2017-10-24
10-Q 2017-06-30 Filed 2017-07-25
10-Q 2017-03-31 Filed 2017-04-25
10-K 2016-12-31 Filed 2017-02-09
10-Q 2016-09-30 Filed 2016-10-25
10-Q 2016-06-30 Filed 2016-07-26
10-Q 2016-03-31 Filed 2016-04-25
10-K 2015-12-31 Filed 2016-02-26
10-Q 2015-09-30 Filed 2015-10-27
10-Q 2015-06-30 Filed 2015-07-29
10-Q 2015-03-31 Filed 2015-04-29
10-K 2014-12-31 Filed 2015-02-25
10-Q 2014-09-30 Filed 2014-10-28
10-Q 2014-06-30 Filed 2014-07-29
10-Q 2014-03-31 Filed 2014-04-29
10-K 2013-12-31 Filed 2014-02-26
10-Q 2013-09-30 Filed 2013-11-12
10-Q 2013-06-30 Filed 2013-07-30
10-Q 2013-03-31 Filed 2013-04-30
10-K 2012-12-31 Filed 2013-02-20
10-Q 2012-09-30 Filed 2012-10-30
10-Q 2012-06-30 Filed 2012-07-26
10-Q 2012-03-31 Filed 2012-04-27
10-K 2011-12-31 Filed 2012-02-28
10-Q 2011-09-30 Filed 2011-10-27
10-Q 2011-06-30 Filed 2011-07-28
10-Q 2011-03-31 Filed 2011-04-28
10-K 2010-12-31 Filed 2011-03-03
10-Q 2010-09-30 Filed 2010-11-04
10-Q 2010-06-30 Filed 2010-07-26
8-K 2019-10-31
8-K 2019-10-28
8-K 2019-10-23
8-K 2019-10-21
8-K 2019-10-11
8-K 2019-10-08
8-K 2019-07-24
8-K 2019-06-16
8-K 2019-06-16
8-K 2019-05-20
8-K 2019-05-17
8-K 2019-04-24
8-K 2019-04-23
8-K 2019-04-10
8-K 2019-03-01
8-K 2019-01-23
8-K 2019-01-22
8-K 2019-01-09
8-K 2018-12-10
8-K 2018-10-17
8-K 2018-10-16
8-K 2018-10-09
8-K 2018-07-18
8-K 2018-07-17
8-K 2018-07-05
8-K 2018-05-21
8-K 2018-05-18
8-K 2018-04-18
8-K 2018-04-17
8-K 2018-04-04
8-K 2018-03-01
8-K 2018-01-24
8-K 2018-01-23
8-K 2018-01-10

LegacyTexas Financial Financials

LTXB Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash515446457061695358748812216690132284192242616317423278289355318327293295260254269275264
Accounts Receivable
Inventory
PP&E484950505453975353539953525186828079113717172110727170109707172115108106
Assets2,9643,2353,1813,0413,6933,6363,6633,3743,5943,3843,5253,6043,9513,9514,1646,5136,6706,8797,6927,5628,0578,4408,3628,4378,9709,0699,0868,8669,2499,0839,0519,3469,936
Accounts Payable
Long-Term Debt1,6141,0611,2681,016
Liabilities2,5572,8292,7742,6293,1873,1203,1422,8433,0612,8442,9813,0533,3943,3863,5965,7515,8936,0866,8886,7397,2147,5737,4777,5378,0458,1198,1267,8868,2488,0437,9578,2258,793
Stockholders' Equity4074074064135065165215315335405445505575645687617777938048238438678859009259509609791,0011,0401,0941,1211,143
Income Statement ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Revenue
Cost of Revenue
Gross Profit888789951620181622232725182829152628432927
R&D
SG&A
Tax234496255434553911109121314148141528671187
Net Income551078111088878995162018162223272518282915262843582927
Cash Flow ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash Operating-259-138112-179-69-31317-124292-419132122-51144341561963-5974352-34854867919
Cash Investing3184329513422-40-77-42293-48-306-79-173-254-266-163-449-171-383-53873-25-575-88-81218-436150-281-577
Cash Financing259-54-146110-7517-293207-23414069329-19220394130179822-183469331-57-64954550-265346-241208547